Treatment-naïve (N=79) | Null responders(N=45) | |
BL HCV RNA (log10 IU/mL) | 6.5±0.6 | 6.6±0.5 |
BL IL28B non-CC genotype | 72% | 96% |
SVR4 | 78/79 (99%) | 42/45 (93%) |
OD SVR12 | 76/77 (99%) | 38/41 (93%) |
PTW12 data missing* | 2 | 4 |
Breakthrough | 0 | 3 |
Relapse | 1 | 0 |
OD SVR12 (GT1a) | 52/53 (98%) | 24/27 (89%) |
OD SVR12 (GT1b) | 24/24 (100%) | 14/14 (100%) |
OD SVR12 (IL28B non-CC) | 54/55 (98%) | 36/39 (92%) |
* | Did not follow up (2 treatment-naïve patients and 1 null responder) or have not yet reached PTW12 (3 null responders) |
欢迎光临 肝胆相照论坛 (http://hbvhbv.info/forum/) | Powered by Discuz! X1.5 |